WallStSmart

Alphatec Holdings Inc (ATEC)vsBoston Scientific Corp (BSX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Boston Scientific Corp generates 2519% more annual revenue ($20.61B vs $787.08M). BSX leads profitability with a 17.3% profit margin vs -15.9%. ATEC appears more attractively valued with a PEG of 0.48. BSX earns a higher WallStSmart Score of 76/100 (B+).

ATEC

Hold

42

out of 100

Grade: D

Growth: 6.7Profit: 2.0Value: 8.3Quality: 4.0
Piotroski: 5/9Altman Z: -1.68

BSX

Strong Buy

76

out of 100

Grade: B+

Growth: 8.0Profit: 7.0Value: 5.3Quality: 6.3
Piotroski: 5/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ATECUndervalued (+34.1%)

Margin of Safety

+34.1%

Fair Value

$20.43

Current Price

$8.00

$12.43 discount

UndervaluedFair: $20.43Overvalued
BSXSignificantly Overvalued (-29.4%)

Margin of Safety

-29.4%

Fair Value

$37.35

Current Price

$48.55

$11.20 premium

UndervaluedFair: $37.35Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ATEC1 strengths · Avg: 10.0/10
PEG RatioValuation
0.4810/10

Growing faster than its price suggests

BSX5 strengths · Avg: 8.6/10
EPS GrowthGrowth
100.0%10/10

Earnings expanding 100.0% YoY

Market CapQuality
$70.87B9/10

Large-cap with strong market position

PEG RatioValuation
0.588/10

Growing faster than its price suggests

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.6%8/10

Strong operational efficiency at 20.6%

Areas to Watch

ATEC4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.27B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-686.7%2/10

ROE of -686.7% — below average capital efficiency

Free Cash FlowQuality
$-10.80M2/10

Negative free cash flow — burning cash

BSX0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : ATEC

The strongest argument for ATEC centers on PEG Ratio. Revenue growth of 13.6% demonstrates continued momentum. PEG of 0.48 suggests the stock is reasonably priced for its growth.

Bull Case : BSX

The strongest argument for BSX centers on EPS Growth, Market Cap, PEG Ratio. Profitability is solid with margins at 17.3% and operating margin at 20.6%. Revenue growth of 11.6% demonstrates continued momentum.

Bear Case : ATEC

The primary concerns for ATEC are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 33.03 is elevated, increasing financial risk.

Bear Case : BSX

No major red flags identified for BSX, but monitor valuation.

Key Dynamics to Monitor

ATEC profiles as a turnaround stock while BSX is a mature play — different risk/reward profiles.

ATEC carries more volatility with a beta of 0.87 — expect wider price swings.

ATEC is growing revenue faster at 13.6% — sustainability is the question.

BSX generates stronger free cash flow (171M), providing more financial flexibility.

Bottom Line

BSX scores higher overall (76/100 vs 42/100), backed by strong 17.3% margins and 11.6% revenue growth. ATEC offers better value entry with a 34.1% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alphatec Holdings Inc

HEALTHCARE · MEDICAL DEVICES · USA

Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.

Boston Scientific Corp

HEALTHCARE · MEDICAL DEVICES · USA

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Want to dig deeper into these stocks?